These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8704029)

  • 41. Adenosine deaminase specific activity in normal, benign hypertrophied and neoplastic human prostate tissue.
    Tritsch GL; Murphy GP
    Eur Urol; 1980; 6(4):229-31. PubMed ID: 6156073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prolyl oligopeptidase: a rising star on the stage of neuroinflammation research.
    Penttinen A; Tenorio-Laranga J; Siikanen A; Morawski M; Rossner S; García-Horsman JA
    CNS Neurol Disord Drug Targets; 2011 May; 10(3):340-8. PubMed ID: 21222623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of aromatase activity in human prostatic, testicular and placental tissues.
    Rowlands MG; Davies JH; Shearer RJ; Dowsett M
    J Enzyme Inhib; 1991; 4(4):307-13. PubMed ID: 1727017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purification, characterization and the use of recombinant prolyl oligopeptidase from Myxococcus xanthus for gluten hydrolysis.
    Kocadag Kocazorbaz E; Zihnioglu F
    Protein Expr Purif; 2017 Jan; 129():101-107. PubMed ID: 27693621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activity of angiotensin-converting enzyme in hereditary stress-induced arterial hypertension.
    Cherkasova OP; Fedorov VI; Markel AL
    Bull Exp Biol Med; 2005 Oct; 140(4):388-90. PubMed ID: 16671560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trypanosoma brucei brucei oligopeptidase B null mutants display increased prolyl oligopeptidase-like activity.
    Kangethe RT; Boulangé AF; Coustou V; Baltz T; Coetzer TH
    Mol Biochem Parasitol; 2012; 182(1-2):7-16. PubMed ID: 22123425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of angiotensin I converting enzyme polymorphism as genetic risk factor in benign prostatic hyperplasia and prostate cancer.
    Hasanzad M; Samzadeh M; Jamaldini SH; Haghdoost AA; Afshari M; Ziaei SA
    Genet Test Mol Biomarkers; 2012 Jul; 16(7):770-4. PubMed ID: 22667764
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia.
    Kucur M; Isman FK; Balci C; Onal B; Hacibekiroglu M; Ozkan F; Ozkan A
    Urol Oncol; 2008; 26(1):47-52. PubMed ID: 18190830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The effect of amidinomercaptic acids on prolyl endopeptidase and carboxycathepsin activity (angiotensin converting enzyme)].
    Alekseenko LP; Eliseeva IuE; Pavlikhina LV; Pozdnev VF; Orekhovich VN
    Dokl Akad Nauk SSSR; 1989; 306(6):1486-9. PubMed ID: 2553370
    [No Abstract]   [Full Text] [Related]  

  • 50. Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats.
    Okamura T; Miyazaki M; Inagami T; Toda N
    Hypertension; 1986 Jul; 8(7):560-5. PubMed ID: 3013774
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The histochemical behaviour, electrophoretic mobility and distribution in cell fractions of acid phosphatase isozymes in prostatic cancer and benign prostate hyperplasia.
    Fischer DR; Gevers W; Klerk JN; Kühn S
    Int Urol Nephrol; 1979; 11(2):111-8. PubMed ID: 89105
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Substrate-dependent, non-hyperbolic kinetics of pig brain prolyl oligopeptidase and its tight binding inhibition by JTP-4819.
    Venäläinen JI; Juvonen RO; Forsberg MM; Garcia-Horsman A; Poso A; Wallen EA; Gynther J; Männistö PT
    Biochem Pharmacol; 2002 Aug; 64(3):463-71. PubMed ID: 12147298
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein.
    Lilja H
    J Clin Invest; 1985 Nov; 76(5):1899-903. PubMed ID: 3902893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Standardization of a fluorimetric assay for the determination of tissue angiotensin-converting enzyme activity in rats.
    Oliveira EM; Santos RA; Krieger JE
    Braz J Med Biol Res; 2000 Jul; 33(7):755-64. PubMed ID: 10881050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural relationship between lipases and peptidases of the prolyl oligopeptidase family.
    Polgár L
    FEBS Lett; 1992 Oct; 311(3):281-4. PubMed ID: 1397329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of prostatic acid phosphatase assays.
    Wise WS; Kandaswamy K
    Arch Pathol Lab Med; 1981 Nov; 105(11):622-5. PubMed ID: 6170271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Creatine phosphokinase isoenzymes in human prostatic tissues: a comparison between benign hyperplasia and adenocarcinoma.
    Truong T; Carmel M; Elhilali M; Cloutier D; Lehoux JG
    Prostate; 1985; 7(2):143-9. PubMed ID: 2413430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prolyl oligopeptidase: an unusual beta-propeller domain regulates proteolysis.
    Fülöp V; Böcskei Z; Polgár L
    Cell; 1998 Jul; 94(2):161-70. PubMed ID: 9695945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enzyme markers in human prostatic carcinoma.
    Chu TM; Wang MC; Kuciel R; Valenzuela L; Murphy GP
    Cancer Treat Rep; 1977; 61(2):193-200. PubMed ID: 68822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Angiotensin-converting enzyme activity of the aorta in experimental hypertensive rats].
    Mizuno K; Gotoh M; Toki T; Matsui J; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1982 Dec; 58(12):1482-6. PubMed ID: 6301898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.